Working together, ImmunoSite Technologies and Goodwin Biotechnology companies offer enhanced abilities to develop, test and manufacture biopharmaceuticals
Cell Culture Course helps Floridians enter, remain and advance in the workforce Full release click here. Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped develop a Cell Culture Workshop that will be offered for the first time October 27 and 28 at [...]
Working together, companies offer enhanced abilities to monitor immunotherapy response in vaccine and drug studies.
Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc. Fort Lauderdale, Fla. – April 3, 2011 – ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a [...]
ImmunoSite Technologies Has Been Working With The “CD4 Initiative” To Develop Quality Assurance Materials For Novel, Disposable, CD4 Point-Of-Care Test For Developing Nations The CD4 Initiative at Imperial College, London, funded by Bill and Melinda Gates Foundation grants, is nearing a major breakthrough in HIV/AIDS care by developing a simple, inexpensive CD4 point-of-care test specifically [...]
